Lower risk
Showing 26 - 50 of >10,000
Infant Formula, Growth Trial in London (Modified infant formula, Standard infant formula)
Active, not recruiting
- Infant Formula
- Growth
- Modified infant formula
- Standard infant formula
-
London, United KingdomUCL Institute of Child Health
Aug 25, 2022
Readmission and Death of Lower Respiratory Infections in Older
Completed
- Lower Respiratory Infection
- +3 more
- no intervention
- (no location specified)
Apr 27, 2022
CCTA to Optimize the Diagnostic Yield of Invasive Angiography
Completed
- Coronary Artery Disease
- Coronary Computed Tomographic Angiography
-
Hamilton, Ontario, CanadaHamilton General Hospital
Mar 14, 2022
Refractory Chronic Myelomonocytic Leukemia, Refractory Myelodysplastic Syndrome Trial in Houston (Fostamatinib)
Recruiting
- Refractory Chronic Myelomonocytic Leukemia
- Refractory Myelodysplastic Syndrome
-
Houston, TexasM D Anderson Cancer Center
Aug 31, 2021
Leukemia, Leukemia, Myeloid, Monocytic Leukemia Trial in Palo Alto (Enasidenib mesylat dose escalation)
Recruiting
- Leukemia
- +2 more
- Enasidenib mesylat dose escalation
-
Palo Alto, CaliforniaStanford Cancer Institute
May 12, 2022
Diabetes, Gestational, PreDiabetes, Diabetes, Type 2 Trial in Boston (Metformin)
Recruiting
- Diabetes, Gestational
- +2 more
-
Boston, MassachusettsTufts Medical Center
Aug 11, 2022
Acute Non-contact Lower Extremity Injuries Prediction
Not yet recruiting
- Sport Injury
- +3 more
- Exposure to risk for injury
- (no location specified)
Jul 5, 2022
PreDiabetes Trial in New York (PAC with HEPA filter intact, PAC with HEPA filter removed)
Not yet recruiting
- PreDiabetes
- PAC with HEPA filter intact
- PAC with HEPA filter removed
-
New York, New YorkNYU Langone Medical Center
Aug 9, 2023
Myelodysplatic Syndromes Trial in Saint-Étienne (Physiological tests to measure fatigue level)
Recruiting
- Myelodysplatic Syndromes
- Physiological tests to measure fatigue level
-
Saint-Étienne, FranceCHU de Saint-Etienne
Feb 7, 2022
Osteoporosis, Osteoarthritis Trial in Loughborough (Ballistic Resistance Lower Body Strength Training, Conventional Resistance
Active, not recruiting
- Osteoporosis
- Osteoarthritis
- Ballistic Resistance Lower Body Strength Training
- Conventional Resistance Lower Body Strength Training
-
Loughborough, Leicestershire, United KingdomLoughborough University
Jun 2, 2023
Patent Foramen Ovale, Atrial Fibrillation, Cryptogenic Stroke Trial in Paris (Flecainide)
Enrolling by invitation
- Patent Foramen Ovale
- +2 more
-
Paris, IDF, FranceHopital Pitié Salpetrière
Jul 22, 2022
Diagnostic and Evaluation Tool for Lower Limb Lymphedema: Aim 2
Not yet recruiting
- Lower Limb Lymphedema
- clinical assessment
-
Leuven, BelgiumUniversity Hospitals of Leuven
Jun 16, 2022
NIRST and ICG-based Perfusion Imaging in Acute Compartment
Recruiting
- Compartment Syndromes
- +2 more
- Lower extremity and/or upper extremity surgery
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Jan 3, 2023
Breast Tumors Trial in London, Ottawa, Thunder Bay (TC-H x Paclitaxel (P) + Trastuzumab(T))
Active, not recruiting
- Breast Neoplasms
- TC-H x Paclitaxel (P) + Trastuzumab(T)
-
London, Ontario, Canada
- +2 more
Jun 8, 2021
the Methodology of the Balance Test Trial (performance based balance test)
Not yet recruiting
- the Methodology of the Balance Test
- performance based balance test
- (no location specified)
Jan 19, 2023
Impact of Catheter Ablation on ABC Risk Scores
Recruiting
- Atrial Fibrillation
- +5 more
- Catheter ablation
-
Hanover, Lower Saxony, GermanyHannover Medical School
Nov 22, 2022
Landing Biomechanics, Fatigue Trial in Gent
Recruiting
- Landing Biomechanics
- Fatigue
-
Gent, Oost-Vlaanderen, BelgiumVakgroep Revalidatiewetenschappen
Dec 3, 2021
Primary MDS Classified as Very Low, Low or Intermediate Risk With <5% Blasts Trial in China (FG-4592, Placebo)
Active, not recruiting
- Primary MDS Classified as Very Low, Low or Intermediate Risk With <5% Blasts
- FG-4592
- Placebo
-
Bengbu, Anhui, China
- +37 more
Aug 17, 2022
Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Ductal Breast Carcinoma In Situ Trial in Houston (Behavioral,
Active, not recruiting
- Deleterious BRCA1 Gene Mutation
- +5 more
- Behavioral, Psychological or Informational Intervention
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Psychosis, Prodromal Schizophrenia, Prodromal Symptoms Trial in Glen Oaks (SCORES (Specific COgnitive Remediation with Support))
Recruiting
- Psychosis
- +2 more
- SCORES (Specific COgnitive Remediation with Support)
-
Glen Oaks, New YorkNorthwell Health- The Zucker Hillside Hospital
Nov 24, 2021
Oakland-Jairath Score Validation
Recruiting
- Lower Gastrointestinal Bleeding
- Oakland-Jairath Risk Score
-
Edmonton, Alberta, Canada
- +3 more
Apr 5, 2022
Triage UltraSound in Tb Endemic Regions
Recruiting
- Tuberculosis
- +2 more
- POCUS
-
Cotonou, Atlantic, Benin
- +2 more
Jun 15, 2022
Severe Rebound Pain After Lower Limb Orthopedic Surgery
Active, not recruiting
- Orthopedic Procedures
- +5 more
- This is not an interventional study
-
Vancouver, British Columbia, CanadaSt. Paul's Hospital
Dec 20, 2021